Duality Biotherapeutics, Inc. announced that the Shanghai Stock Exchange (SSE) has formally accepted the company’s application materials for an initial public offering of RMB ordinary shares (A Shares) on the Science and Technology Innovation Board (STAR Market). The submission includes the “Initial Public Offering of RMB Ordinary Shares (A Shares) and Listing on the Science and Technology Innovation Board Prospectus (Application Proof),” which will be available on the SSE website.

The proposed RMB Share Issue remains subject to subsequent regulatory approvals and therefore may or may not proceed. Duality Biotherapeutics emphasized that shareholders and potential investors should exercise caution when dealing in the company’s shares.

Further updates will be released in accordance with Hong Kong Listing Rules and other applicable regulations.